Table 1.
Characteristics of participants from the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) and the Busselton Health Study (BHS).
| AusDiab | BHS | |
|---|---|---|
| #Subjects | 10,339 | 4492 |
| Demographic | ||
| Sex (%male) | 4654 (45.0) | 1976 (44.0) |
| Age (years, mean ± sd) | 51.3 (±14.3) | 50.8 (±17.4) |
| BMI (kg/m2, mean ± sd) | 26.9 (±4.9) | 26.2 (±4.2) |
| Clinical lipids | ||
| Cholesterol (nmol/L, mean ± sd) | 5.66 (±1.07) | 5.58 (±1.11) |
| HDL-C (nmol/L, mean ± sd) | 1.44 (±0.39) | 1.39 (±0.39) |
| Triglycerides (nmol/L, mean ± sd)a | 1.28 (±0.92) | 1.18 (±0.90) |
| Other cardiometabolic risk factors | ||
| SBP (mmHg) | 129.2 (±18.6) | 124.0 (±17.9) |
| DBP (mmHg) | 70.0 (±11.7) | 74.5 (±10.2) |
| FBG (mmol/L) | 5.2 (±1.1) | 5.0 (±1.4) |
| 2 h-PLG (mmol/L) | 6.3 (±2.7) | – |
| Prevalent clinical outcomes at baseline | ||
| Prevalent diabetes (%)b | 395 (3.8) | 271 (6.0) |
| Prevalent CVD (%) | 577 (5.6) | 238 (5.3) |
| Incident clinical outcomes | ||
| Major CVE (%) (12 years follow up) | 444 (4.3) | – |
| Incident IHD (%) | 329 (3.2)c | 284 (2.8)d/551 (5.3)e |
| Stroke (%) (12 years follow up) | 95 (0.9) | – |
| All-cause mortality (%) (17 years follow up) | 1706 (16.5) | – |
a
Data in Median, (IQR) as Triglyceride distribution was right skewed.
b
Prevalent diabetes only include the untreated prevalent cases.
c
Incident IHD cases with 12 years follow up in AusDiab.
d
Incident IHD cases with 10 years follow up in BHS.
e
Incident IHD cases with 20 years follow up in BHS.